How big is the myomectomy market today, and what are its future growth expectations?
The myomectomy market size has grown strongly in recent years. It will grow from $1.5 billion in 2024 to $1.62 billion in 2025 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to the growing prevalence of uterine fibroids, increasing advancements in surgical technology, increased awareness of treatment options, rising patient demand for effective solutions, and rising improvements in healthcare infrastructure.
The myomectomy market size is expected to see strong growth in the next few years. It will grow to $2.23 billion in 2029 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to a rise in the number of women seeking fertility-preserving treatments, expanding access to specialized gynecological care, increasing investment in healthcare technology innovation, the growing prevalence of uterine disorders, rise in healthcare expenditure on advanced surgical interventions. Major trends in the forecast period include minimally invasive and robotic-assisted surgical techniques, integration of artificial intelligence in surgical planning, the development of personalized treatment plans based on genetic profiling, advancements in non-invasive diagnostic tools, a rise in patient demand for fertility-preserving options, expanding global access to advanced surgical technologies, focus on patient-centered care and postoperative recovery improvements.
Get Your Free Sample of The Global Myomectomy Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20576&type=smp
What have been the primary factors driving the myomectomy market’s growth?
The rising prevalence of uterine disorders is expected to propel the growth of the myomectomy market going forward. Uterine disorders refer to a range of medical conditions affecting the uterus, including fibroids, endometriosis, and uterine cancer, that can lead to symptoms such as pain, abnormal bleeding, and infertility. The rising prevalence of uterine disorders is attributed to factors such as increased awareness, delayed childbearing, hormonal imbalances, and lifestyle changes. Myomectomy is used in uterine disorders to surgically remove fibroids, alleviating symptoms such as pain, heavy bleeding, and reproductive complications while preserving the uterus. For instance, in January 2024, according to Cancer Australia, an Australia-based cancer control agency, in 2020, uterine cancer caused 561 deaths in the country, with projections showing an increase to 667 deaths by 2022. Therefore, the rising prevalence of uterine disorders is driving the growth of the myomectomy market.
>Myomectomy Market Driver: Surge in Demand for Minimally Invasive Techniques Fuels Myomectomy Device Market Growth
The growing demand for minimally invasive techniques is expected to propel the growth of the myomectomy market going forward. Minimally invasive surgeries refer to surgical approaches that use small incisions or natural body openings to access and treat internal structures, organs, or tissues to minimize trauma to the patient’s body. Minimally invasive techniques provide medical, financial, and aesthetic benefits that appeal to patients and healthcare providers, driving the increasing demand across various medical disciplines. Occlusion devices are medical tools used in minimally invasive procedures to block or close off blood vessels, ducts, or other pathways in the body. These devices are often used in interventional cardiology, radiology, or other fields to treat conditions such as aneurysms, abnormal blood flow, or congenital heart defects. For instance, in January 2023, according to Intuitive Surgical Inc., a US-based technology corporation specializing in minimally invasive care products, in 2022, approximately 1,875,000 surgical procedures were performed with vinci surgical systems, an increase of roughly 18% compared with approximately 1,594,000 surgical procedures performed in 2021. Therefore, the growing demand for minimally invasive techniques drives the growth of the myomectomy devices market.
What are the key segments within the myomectomy market?
The myomectomy market covered in this report is segmented —
1) By Type: Abdominal Myomectomy, Hysteroscopic Myomectomy, Laparoscopic Myomectomy
2) By Product: Laparoscopic Power Morcellators, Harmonic Scalpel, Laparoscopic Sealer, Other Products
3) By End-User: Hospitals And Clinics, Surgical Centers, Medical Device Companies, Other End-Users
Subsegments:
1) By Abdominal Myomectomy: Open Abdominal Myomectomy (Laparotomy), Mini-Laparotomy Myomectomy
2) By Hysteroscopic Myomectomy: Resectoscopic Myomectomy, Non-Resectoscopic Techniques
3) By Laparoscopic Myomectomy: Conventional Laparoscopic Myomectomy, Robotic-Assisted Laparoscopic Myomectomy
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/myomectomy-global-market-report
Which key players are shaping the myomectomy market?
Major companies operating in the myomectomy market are AbbVie Inc., Medtronic plc, Stryker Corporation, Mayo Clinic, Boston Scientific Corporation, Johnson Hopkins Medicines, B. Braun Melsungen AG, Olympus Corporation, Intuitive Surgical Inc., Smith & Nephew plc, Hologic Inc., Columbia University Irving Medical Center, CooperSurgical Inc., Teleflex Incorporated, Karl Storz SE & Co. KG, CONMED Corporation, Richard Wolf GmbH, Park Hospital, Phoenix Medical Devices, ERBE Elektromedizin GmbH, Advin Health Care, Sterling Surgicals, LiNA Medical ApS
How will emerging trends drive the myomectomy market throughout the forecast period?
Major companies operating in the myomectomy market are focused on developing advanced gynecologic procedures such as the tissue extraction system to improve surgical outcomes and provide minimally invasive options for patients undergoing myomectomy. The Tissue Extraction System is a medical device created to assist in the removal of large tissue specimens during minimally invasive gynecologic surgeries, such as myomectomy. For instance, in November 2022, Olympus Corporation, a Japan-based manufacturer of optics and reprography products, launched the New Gynecologic Power Morcellator. The Morcellation Morcellator, a part of the Olympus-contained tissue extraction system, is specifically designed for advanced gynecologic procedures involving large, calcified tissue specimens. When used with the PneumoLiner containment device, it provides select patients with a minimally invasive alternative to open hysterectomy or myomectomy.
How do regional factors impact the myomectomy market, and which region is the largest contributor?
North America was the largest region in the myomectomy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the myomectomy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Myomectomy Market Report 2025 Offer?
The myomectomy market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Myomectomy is a surgical procedure designed to remove uterine fibroids (benign growths) while keeping the uterus intact. It helps relieve symptoms such as heavy bleeding, pain, and pressure associated with fibroids. This procedure can also enhance fertility and is often recommended for women who want to preserve their uterus.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20576
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
